LOAN AGREEMENTLoan Agreement • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
THIS LOAN AGREEMENT (this “Agreement”) is dated as of August 25, 2006, by and among BIOPORT CORPORATION, a Michigan corporation, which maintains its chief executive office at 3500 N. Martin Luther King, Jr. Blvd., Building One, Third Floor, Lansing, Michigan 48906 (the “Borrower”), and EMERGENT BIOSOLUTIONS INC., a Delaware corporation (the “Guarantor”) and HSBC REALTY CREDIT CORPORATION (USA), a Delaware corporation (the “Bank”).
AMENDED AND RESTATED MARKETING AGREEMENTMarketing Agreement • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Michigan
THIS AMENDED AND RESTATED MARKETING AGREEMENT (the “Agreement”) is made effective this 1st day of January 2000 (the “Effective Date”), by and between BioPort Corporation, a Michigan corporation having its principal office at 3500 N. Martin Luther King, Jr., Blvd., Lansing Michigan 48906 (“BIOPORT”) and INTERGEN N.V., a corporation of the Netherlands Antilles, its address being c/o Tarma Trust Management, Castorweg 22-24, Curacao, Netherlands Antilles (“INTERGEN”) (BIOPORT and INTERGEN being sometimes referred to in the singular as “Party” and collectively as “Parties”).
STANDARD EMPLOYMENT CONTRACTEmployment Contract • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations
This statement sets out the Terms & Conditions of employment between Emergent Product Development UK Ltd (formerly Emergent Europe Limited) of 540~545 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TU, UK.
SERVICES AGREEMENTServices Agreement • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Maryland
Services Agreement (“Agreement”), effective as of August 1, 2006, is entered into by and between East West Resources Corporation, a corporation organized under the laws of the District of Columbia (“EWR”), and Emergent BioSolutions Inc., a corporation organized under the laws of the state of Delaware (“Emergent” and together with EWR, a “Party” or the “Parties”).
CLASS A STOCKHOLDERS’ REGISTRATION RIGHTS AGREEMENTStockholders’ Registration Rights Agreement • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
THIS CLASS A STOCKHOLDERS’ REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of September 22, 2006, by and among Emergent Biosolutions, Inc., a Delaware corporation (together with any successor thereto, the “Company”) and the holders of the Company’s Class A Common Stock, $0.01 par value per share, listed on Exhibit A attached hereto (each, a “Stockholder” and together, the “Stockholders”). The Company and each of the Stockholders are referred to herein as a “Party” and collectively, as the “Parties”.
LEASE AGREEMENT BRANDYWINE RESEARCH LLC Landlord and EMERGENT BIOSOLUTIONS INC. Tenant 2273 Research Boulevard Rockville, Maryland 20850 Dated: June 27, 2006Lease Agreement • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Maryland
THIS LEASE AGREEMENT (this “Lease”) is entered into as of June 27, 2006, between BRANDYWINE RESEARCH LLC, a Delaware limited liability company (“Landlord”), and EMERGENT BIOSOLUTIONS INC., a Delaware corporation, having a place of business at 300 Professional Drive, Suite 250, Gaithersburg, Maryland 20879 (“Tenant”).
VOTING AGREEMENTVoting Agreement • September 25th, 2006 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
VOTING AGREEMENT, effective as of August 11, 2006 (this “Agreement”), by and between BIOPHARM, LLC, a Delaware limited liability company (“BioPharm”) and MICROSCIENCE INVESTMENTS LIMITED, a limited company organized under the laws of England and Wales (“Microscience”).
